跳至主要内容
临床试验/NCT04689555
NCT04689555已完成不适用

Safety and Efficacy of Femoral Artery Hemostasis Without Manual Compression After Femoral Artery Puncture (FAST): a Prospective, Randomized, Open-label, Controlled, Multicenter Trial

Second Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,200
试验地点
1
主要终点
Composite of arterial access related complications

研究概览

简要总结

FAST trial is a prospective, randomized, controlled, multicenter study in participants needing hemostasis after femoral arterial puncture. All eligible participants will be randomly assigned to either manual compression or novel method without manual compression after femoral arterial puncture. This study is aimed to investigate if novel method without manual compression is noninferior to manual compression regarding access site complications.

详细描述

The common femoral artery is the most frequently used access site in cardiovascular interventional therapy. Closure of the arteriotomy site is usually achieved by manual compression after femoral arterial puncture. There are many disadvantages of this standard method for hemostasis which is still related to high rate of access-site complications such as pseudoaneurysm, major bleeding, ipsilateral groin hematomas and so on. Several vascular closure devices are emerging as novel means for improving patient comfort and accelerating ambulation after invasive cardiovascular procedures performed via femoral arterial access, however, the cost performance and other aspects limit its wide application especially in developing countries.

Actually the investigators found a novel method for femoral artery hemostasis without manual compression. After sheath removal, four or five sterile gauzes were overlaid layer by layer and then bandaged without the procedure of manual compression.

FAST trial is aimed to investigate if the safety and efficacy of this novel method without manual compression is noninferior to the standard manual compression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing femoral access cardiovascular interventional therapy
  • Patient must be competent for providing informed written consent

排除标准

  • Peripheral arterial occlusive disease
  • Prior peripheral artery surgery
  • Critical limb ischemic
  • Femoral arterial intubation failure
  • Uncontrolled hypertension >220/110 mmHg
  • Coagulopathy (bleeding disorder)
  • Local infection
  • Pregnancy

结局指标

主要结局

Composite of arterial access related complications

时间窗: 1 month

Composite of arterial access related complications, defined as the composite of: * Rate of ipsilateral groin hematomas with largest diameter exceeding 5 cm * Pseudoaneurysm * AV-Fistula * Major bleeding * Critical limb ischemia * Local infection * Need for vascular surgical or interventional treatment

次要结局

  • Total procedure time(1 month)
  • Repeat manual compression(1 month)
  • Time to hemostasis(1 month)

研究者

发起方
Second Xiangya Hospital of Central South University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shenghua Zhou

Professor

Second Xiangya Hospital of Central South University

研究点 (1)

Loading locations...

相似试验